Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £27.89 billion [US$35.48 billion]
of which 58%
Roche Holding Aktiengesellschaft
(50.58 billion Swiss Francs [US$52.14 billion]
of which 77%
was Pharmaceuticals), and
based in Switzerland
(48.88 billion Swiss Francs [US$50.39 billion]
of which 66%
was innovative medicines).
During the year ended December of 2016, sales at
Sanofi S.A. were 34.71 billion Euro (US$38.87 billion).
decrease of 0.4%
versus 2015, when the company's sales were 34.86 billion Euro.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Sanofi S.A. had sales
of 33.39 billion Euro.
Contributing to the drop in overall sales was the 3.5% decline
in Vaccines, from 4.74 billion Euro to 4.58 billion Euro.
There were also decreases in sales in
Pharmaceuticals (down 1.9% to 29.24 billion Euro)